Clinical characteristics of pulmonary cryptococcosis coexisting with lung adenocarcinoma: Three case reports

Gui-Xian Zheng1, Hai-Juan Tang1, Zhi-Ping Huang1

  • 1Department of Respiratory Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.

Abstract

Insights

Pulmonary cryptococcosis (PC) can mimic lung cancer on CT scans. This report highlights three cases of PC coexisting with lung adenocarcinoma, emphasizing early diagnosis and treatment for better outcomes.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Oncology

Background:

  • Pulmonary cryptococcosis (PC) is an invasive fungal infection caused by Cryptococcus species, affecting both immunocompetent and immunocompromised individuals.
  • Radiographic findings of PC, particularly pulmonary nodules or masses, can resemble lung cancer, complicating differential diagnosis.
  • Coexistence of PC and lung malignancies is uncommon but clinically significant.

Observation:

  • This report details three cases of concurrent pulmonary cryptococcosis and lung adenocarcinoma.
  • Diagnosis was established through video-assisted thoracic surgery lung biopsy.
  • All three cases were successfully managed with early diagnosis and treatment.

Findings:

  • The study identifies pulmonary nodules/masses on CT scans as a common manifestation of PC.
  • It underscores the potential for misdiagnosis due to overlapping imaging features between PC and lung cancer.
  • The successful management of coexisting PC and adenocarcinoma is demonstrated.

Implications:

  • This case series serves as a crucial reminder for clinicians to consider PC in the differential diagnosis of lung nodules, even in the presence of adenocarcinoma.
  • Prompt diagnosis and integrated treatment strategies are vital for improving patient prognosis in such complex cases.
  • Further research into the diagnostic and therapeutic challenges of coexisting fungal infections and lung cancer is warranted.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.2K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
610
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.2K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
915
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
511